Drug Patents owned by Organon Sub Merck
1. List of Bridion drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| USRE44733 | ORGANON SUB MERCK | 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block |
Jan, 2026
(2 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Patient Population (NPP) | Jun 25, 2024 |
| M (M) | Jun 9, 2023 |
Drugs and Companies using SUGAMMADEX SODIUM ingredient
Market Authorisation Date: 15 December, 2015
Treatment: Reversal of drug-induced neuromuscular block
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of BRIDION before it's patent expiration?
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic